EUROPEAN MEDICINES AGENCY AUTHORIZES DEFERRAL OF PAEDIATRIC INVESTIGATION PLAN FOR TROGARZO™

Aug 20, 2018
PDF Version
Supporting Materials:

Theratechnologies Inc. (Theratechnologies) (TSX: TH) today announced that the Paediatric Committee of the European Medicines Agency (“EMA”) has accepted to defer the initiation of the Paediatric Investigation Plan for TrogarzoTM after the application for marketing authorization in Europe for TrogarzoTM has been filed with the EMA.